Network origin in Matthias Baumann first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
24
| Subsidiary | Pharmaceuticals: Major | 24 |
Friedrich-Alexander University of Erlangen-Nuremberg
22
| College/University | Other Consumer Services | 22 |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.
15
| Subsidiary | Miscellaneous Commercial Services | 15 |
| Public Company | Miscellaneous Commercial Services | 8 | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.
2
| Subsidiary | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Matthias Baumann via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Chairman Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Human Resources Officer | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| University of Basel | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| Freie Universität Berlin | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| QIAGEN N.V. | Medical Specialties | Chairman Director/Board Member | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| NESTLÉ S.A. | Food: Major Diversified | Director/Board Member Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Chief Executive Officer | |
| University of Maryland | College/University | Doctorate Degree Undergraduate Degree | |
| University of London | College/University | Doctorate Degree Undergraduate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Director/Board Member Doctorate Degree | |
| University of Freiburg | College/University | Corporate Officer/Principal Undergraduate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Lausanne | College/University | Undergraduate Degree Undergraduate Degree | |
| ACINO HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Strasbourg | College/University | Undergraduate Degree Undergraduate Degree | |
| RWTH Aachen University | College/University | Doctorate Degree Undergraduate Degree | |
| University of Innsbruck | College/University | Doctorate Degree Doctorate Degree | |
| OSRAM LICHT AG | Auto Parts: OEM | Director/Board Member Chairman | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor Founder | |
OSRAM GmbH
 OSRAM GmbH Electrical ProductsProducer Manufacturing OSRAM GmbH develops and manufactures lamps and lighting systems. Its products include light-emitting diode systems, luminaires, electronic control gears, and lamps. The product applications include indoor and outdoor lighting, light management systems, vehicle and bicycle lighting, as well as specialty lighting. The company was founded in 1906 and is headquartered in Munich, Germany. | Electrical Products | Director/Board Member Chairman | |
| University of Kiel | College/University | Doctorate Degree Doctorate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
Corange Ltd.
 Corange Ltd. Pharmaceuticals: GenericHealth Technology Part of Roche Holding AG, Corange Ltd. is a Bermudian company that manufactures orthopedic and diagnostics equipment. The company is based in Hamilton, Bermuda. Corange was acquired by Roche Holding AG on May 01, 1997 for $10,930.22 million. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| University of Regensburg | College/University | Undergraduate Degree Doctorate Degree | |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Chairman Founder | |
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Medical/Nursing Services | Director/Board Member Chief Operating Officer | |
| The Pennsylvania State University | College/University | Masters Business Admin Undergraduate Degree | |
TeGenero AG
 TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistics
International
| Germany | 18 |
| United States | 14 |
| Switzerland | 12 |
| United Kingdom | 4 |
| France | 3 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 17 |
| Finance | 6 |
| Producer Manufacturing | 3 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 346 |
| Corporate Officer/Principal | 178 |
| Chairman | 151 |
| Chief Executive Officer | 79 |
| Independent Dir/Board Member | 59 |
Most connected contacts
| Insiders | |
|---|---|
| Franz Humer | 45 |
| Bradley Bolzon | 41 |
| Jean-Luc Bélingard | 40 |
| Gerhard Schmidt | 37 |
| Erich Maximilian Platzer | 31 |
| Gerald Heinz Möller | 29 |
| Erich Hunziker | 28 |
| António Jorge Viegas de Vasconcelos | 27 |
| Carole Nüchterlein | 26 |
| Werner Brandt | 22 |
| Pamela Kirby | 22 |
| Richard T. Laube | 21 |
| Patrick Baeuerle | 19 |
| Heino von Prondzynski | 19 |
| Ulrich Winzenried | 18 |
- Stock Market
- Insiders
- Matthias Baumann
- Company connections
